{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:28:35Z","timestamp":1776425315639,"version":"3.51.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s10067-014-2559-5","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T03:52:58Z","timestamp":1393991578000},"page":"623-629","source":"Crossref","is-referenced-by-count":17,"title":["Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis"],"prefix":"10.1007","volume":"33","author":[{"given":"G\u00e1bor","family":"Fut\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Somogyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"key":"2559_CR1","author":"JS Smolen","year":"2013","unstructured":"Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C et al (2013) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-204573","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2559_CR2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.24123","volume":"59","author":"D Aletaha","year":"2008","unstructured":"Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C et al (2008) Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR\/ACR collaborative recommendations. Arthritis Rheum 59(10):1371\u20131377","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2559_CR3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.49.11.916","volume":"49","author":"DM Heijde van der","year":"1990","unstructured":"van der Heijde DM, van\u2018t Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49(11):916\u2013920","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2559_CR4","first-page":"579","volume":"20","author":"DM Heijde van der","year":"1993","unstructured":"van der Heijde DM, van\u2018t Hof M, van Riel PL, van de Putte LB (1993) Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20(3):579\u2013581","journal-title":"J Rheumatol"},{"issue":"5 Suppl 39","key":"2559_CR5","first-page":"S100","volume":"23","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Smolen J (2005) The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23(5 Suppl 39):S100\u2013S108","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"2559_CR6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.berh.2007.02.004","volume":"21","author":"D Aletaha","year":"2007","unstructured":"Aletaha D, Smolen JS (2007) The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. Best Pract Res Clin Rheumatol 21(4):663\u2013675","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"2559_CR7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G et al (2003) A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42(2):244\u2013257","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2559_CR8","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1186\/ar1740","volume":"7","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K et al (2005) Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 7(4):R796\u2013R806","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"2559_CR9","first-page":"552","volume":"27","author":"F Salaffi","year":"2009","unstructured":"Salaffi F, Cimmino MA, Leardini G, Gasparini S, Grassi W (2009) Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI). Clin Exp Rheumatol 27(4):552\u2013559","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2559_CR10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/art.27740","volume":"63","author":"JS Smolen","year":"2011","unstructured":"Smolen JS, Aletaha D (2011) Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants. Arthritis Rheum 63(1):43\u201352","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2559_CR11","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3899\/jrheum.090831","volume":"37","author":"MJ Bentley","year":"2010","unstructured":"Bentley MJ, Greenberg JD, Reed GW (2010) A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research. J Rheumatol 37(8):1607\u20131614","journal-title":"J Rheumatol"},{"issue":"5","key":"2559_CR12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/03009740902932835","volume":"38","author":"B Rintelen","year":"2009","unstructured":"Rintelen B, Sautner J, Haindl PM, Andel I, Maktari A, Leeb BF (2009) Comparison of three rheumatoid arthritis disease activity scores in clinical routine. Scand J Rheumatol 38(5):336\u2013341","journal-title":"Scand J Rheumatol"},{"key":"2559_CR13","doi-asserted-by":"crossref","unstructured":"Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loet X, et al (2012) Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Joint Bone Spine\u00a079(2):149\u2013155","DOI":"10.1016\/j.jbspin.2011.04.008"},{"issue":"2","key":"2559_CR14","first-page":"358","volume":"26","author":"MJ Bentley","year":"2008","unstructured":"Bentley MJ, Reed GW (2008) Simplified composite disease activity measures in rheumatoid arthritis: should they be used in standard care? Clin Exp Rheumatol 26(2):358\u2013366","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"2559_CR15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/ard.2008.092577","volume":"68","author":"M Dougados","year":"2009","unstructured":"Dougados M, Schmidely N, Le Bars M, Lafosse C, Schiff M, Smolen JS et al (2009) Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data. Ann Rheum Dis 68(4):484\u2013489","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2559_CR16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C et al (2010) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69(6):964\u2013975","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2559_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/art.23247","volume":"59","author":"GR Burmester","year":"2008","unstructured":"Burmester GR, Ferraccioli G, Flipo RM, Monteagudo-Saez I, Unnebrink K, Kary S et al (2008) Clinical remission and\/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study. Arthritis Rheum 59(1):32\u201341","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2559_CR18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631\u2013637","journal-title":"Ann Rheum Dis"},{"key":"2559_CR19","doi-asserted-by":"crossref","unstructured":"Aletaha D, Smolen JS\u00a0(2011) Joint damage progresses in DAS28 remission and is driven by residual swollen joints. Arthritis Rheum. doi: 10.1002\/art.30634","DOI":"10.1002\/art.30634"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2559-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2559-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2559-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:32Z","timestamp":1559120252000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2559-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["2559"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2559-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,6]]}}}